Glycostem Therapeutics B.V. is located in Oss, Netherlands on Kloosterstraat 9. Glycostem Therapeutics B.V. is rated 3.1 out of 5 in the category biotechnology in Netherlands. Glycostem Therapeutics is a Dutch biotech company. Glycostem Therapeutics is the trade name of the legal entity IPD Therapeutics BV, which has been established in December 2007. Glycostem Therapeutics has developed the world's first GMP compliant NK cell platform that is ready for industrial scale-up.
Company size
11-50 employees
Accessibility
Wheelchair-accessible entrance